These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8928594)

  • 1. [Clinical effects of verapamil in the treatment of Peyronie's disease].
    Arena F; Peracchia G; Di Stefano C; Passari A; Larosa M; Cortellini P
    Acta Biomed Ateneo Parmense; 1995; 66(6):269-72. PubMed ID: 8928594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intralesional verapamil injection for the treatment of Peyronie's disease.
    Levine LA; Merrick PF; Lee RC
    J Urol; 1994 Jun; 151(6):1522-4. PubMed ID: 8189561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional verapamil for the treatment of Peyronie's disease: a review.
    Levine LA; Estrada CR
    Int J Impot Res; 2002 Oct; 14(5):324-8. PubMed ID: 12454681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraplaque verapamil injection for treatment of Peyronie's disease.
    Lasser A; Vandenberg TL; Vincent MJ; Hellstrom WJ
    J La State Med Soc; 1998 Sep; 150(9):431-4. PubMed ID: 9785755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
    Asali M; Asali M
    Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Peyronie's disease with intralesional verapamil injection.
    Levine LA
    J Urol; 1997 Oct; 158(4):1395-9. PubMed ID: 9302129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.
    Di Stasi SM; Giannantoni A; Stephen RL; Capelli G; Giurioli A; Jannini EA; Vespasiani G
    J Urol; 2004 Apr; 171(4):1605-8. PubMed ID: 15017231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A snapshot of intralesional verapamil injection in the treatment of Peyronie's disease today.
    Sadagopan A
    Andrologia; 2019 Nov; 51(10):e13388. PubMed ID: 31475740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.
    Shirazi M; Haghpanah AR; Badiee M; Afrasiabi MA; Haghpanah S
    Int Urol Nephrol; 2009; 41(3):467-71. PubMed ID: 19199072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
    Cavallini G; Modenini F; Vitali G
    Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of current nonsurgical management of Peyronie's disease.
    Levine LA
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S113-20. PubMed ID: 14551587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.
    Garrido Abad P; Coloma A; Herranz LM; Jiménez M; Suárez C; Prieto MD; Formoso T; Fernández Arjona M
    Arch Esp Urol; 2012 Oct; 65(8):745-51. PubMed ID: 23117682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study.
    Favilla V; Russo GI; Privitera S; Castelli T; Madonia M; La Vignera S; Condorelli R; Calogero AE; Farina FP; Cimino S; Morgia G
    Andrologia; 2014 Oct; 46(8):936-42. PubMed ID: 24124921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iontophoresis for treatment of Peyronie's disease.
    Riedl CR; Plas E; Engelhardt P; Daha K; Pflüger H
    J Urol; 2000 Jan; 163(1):95-9. PubMed ID: 10604323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
    Fitch WP; Easterling WJ; Talbert RL; Bordovsky MJ; Mosier M
    J Sex Med; 2007 Mar; 4(2):477-84. PubMed ID: 17367443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with intraplaque injection of verapamil for Peyronie's disease.
    Levine LA; Goldman KE; Greenfield JM
    J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of intralesional injection of verapamil in treatment of Peyronie's disease.
    Heidari M; Nejadi JR; Ghate A; Delfan B; Iran-Pour E
    J Pak Med Assoc; 2010 Apr; 60(4):291-3. PubMed ID: 20419973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.